Free Trial

Johnson Matthey (OTCMKTS:JMPLY) Sets New 1-Year High - What's Next?

Johnson Matthey logo with Basic Materials background

Key Points

  • Johnson Matthey PLC's share price has reached a new 52-week high of $53.13, marking a notable increase from its previous close of $52.08.
  • Recent analyst activity includes Kepler Capital Markets and Zacks Research both upgrading the stock to a "hold" rating, resulting in an average rating of "Hold" for the company.
  • The company maintains a debt-to-equity ratio of 0.57, indicating a stable financial position, with current and quick ratios suggesting good liquidity.
  • Five stocks to consider instead of Johnson Matthey.

Johnson Matthey PLC (OTCMKTS:JMPLY - Get Free Report)'s share price reached a new 52-week high on Friday . The stock traded as high as $53.13 and last traded at $53.13, with a volume of 716 shares traded. The stock had previously closed at $52.08.

Wall Street Analyst Weigh In

JMPLY has been the topic of several analyst reports. Kepler Capital Markets raised Johnson Matthey to a "hold" rating in a report on Wednesday, June 25th. Zacks Research raised shares of Johnson Matthey from a "strong sell" rating to a "hold" rating in a research report on Monday, August 18th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of "Hold".

Read Our Latest Stock Report on JMPLY

Johnson Matthey Trading Up 2.2%

The business's fifty day moving average price is $50.35 and its 200-day moving average price is $43.68. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.01 and a current ratio of 1.42.

About Johnson Matthey

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Johnson Matthey Right Now?

Before you consider Johnson Matthey, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.

While Johnson Matthey currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.